ReviewCureus2022

A Systematic Review on the Safety and Efficacy of PCSK9 Inhibitors in Lowering Cardiovascular Risks in Patients With Chronic Kidney Disease.

Emmanuelar O Igweonu-Nwakile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.